Suppr超能文献

含有多种抗体和寡核苷酸用于多靶点药物递送的聚(苹果酸)纳米共轭物。

Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.

作者信息

Ljubimova Julia Y, Fujita Manabu, Ljubimov Alexander V, Torchilin Vladimir P, Black Keith L, Holler Eggehard

机构信息

Cedars-Sinai Medical Center, Department of Neurosurgery, 8631 West Third Street, Suite 800E, Los Angeles, CA 90048, USA.

出版信息

Nanomedicine (Lond). 2008 Apr;3(2):247-65. doi: 10.2217/17435889.3.2.247.

Abstract

Nanoconjugates are emerging as promising drug-delivery vehicles because of their multimodular structure enabling them to actively target discrete cells, pass through biological barriers and simultaneously carry multiple drugs of various chemical nature. Nanoconjugates have matured from simple devices to multifunctional, biodegradable, nontoxic and nonimmunogenic constructs, capable of delivering synergistically functioning drugs in vivo. This review mainly concerns the Polycefin family of natural-derived polymeric drug-delivery devices as an example. This type of vehicle is built by hierarchic conjugation of functional groups onto the backbone of poly(malic acid), an aliphatic polyester obtained from the microorganism Physarum polycephalum. Particular Polycefin variants target human brain and breast tumors implanted into animals specifically and actively and could be detected easily by noninvasive imaging analysis. Delivery of antisense oligonucleotides to a tumor-specific angiogenic marker using Polycefin resulted in significant inhibition of tumor angiogenesis and increase of animal survival.

摘要

纳米缀合物正作为一种有前景的药物递送载体而兴起,因为其多模块结构使其能够主动靶向离散细胞、穿过生物屏障并同时携带多种具有不同化学性质的药物。纳米缀合物已从简单的装置发展成为多功能、可生物降解、无毒且无免疫原性的构建体,能够在体内递送具有协同作用的药物。本综述主要以天然衍生的聚合物药物递送装置聚西芬家族为例。这类载体是通过将官能团分层缀合到聚(苹果酸)主链上构建而成,聚(苹果酸)是一种从多头绒泡菌微生物中获得的脂肪族聚酯。特定的聚西芬变体能够特异性且主动地靶向植入动物体内的人脑肿瘤和乳腺肿瘤,并且可以通过非侵入性成像分析轻松检测到。使用聚西芬将反义寡核苷酸递送至肿瘤特异性血管生成标志物可显著抑制肿瘤血管生成并延长动物存活时间。

相似文献

3
Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
J Control Release. 2007 Oct 8;122(3):356-63. doi: 10.1016/j.jconrel.2007.05.032. Epub 2007 Jun 5.
4
Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis.
Angiogenesis. 2006;9(4):183-91. doi: 10.1007/s10456-006-9046-9. Epub 2006 Nov 16.
5
Quantitative analysis of PMLA nanoconjugate components after backbone cleavage.
Int J Mol Sci. 2015 Apr 16;16(4):8607-20. doi: 10.3390/ijms16048607.
6
Nanoconjugate based on polymalic acid for tumor targeting.
Chem Biol Interact. 2008 Jan 30;171(2):195-203. doi: 10.1016/j.cbi.2007.01.015. Epub 2007 Feb 8.
7
Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
J Drug Target. 2013 Dec;21(10):956-967. doi: 10.3109/1061186X.2013.837470. Epub 2013 Sep 16.
9
Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected].
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18143-8. doi: 10.1073/pnas.1003919107. Epub 2010 Oct 4.

引用本文的文献

1
Clinical developments of antitumor polymer therapeutics.
RSC Adv. 2019 Aug 8;9(43):24699-24721. doi: 10.1039/c9ra04358f.
2
Polymer nanomedicines.
Adv Drug Deliv Rev. 2020;156:40-64. doi: 10.1016/j.addr.2020.07.020. Epub 2020 Jul 28.
3
Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.
J Control Release. 2020 Apr 10;320:45-62. doi: 10.1016/j.jconrel.2020.01.009. Epub 2020 Jan 7.
4
A Combination of Tri-Leucine and Angiopep-2 Drives a Polyanionic Polymalic Acid Nanodrug Platform Across the Blood-Brain Barrier.
ACS Nano. 2019 Feb 26;13(2):1253-1271. doi: 10.1021/acsnano.8b06437. Epub 2019 Jan 16.
5
Covalent nano delivery systems for selective imaging and treatment of brain tumors.
Adv Drug Deliv Rev. 2017 Apr;113:177-200. doi: 10.1016/j.addr.2017.06.002. Epub 2017 Jun 10.
6
Preparation of Two Types of Polymeric Micelles Based on Poly(β-L-Malic Acid) for Antitumor Drug Delivery.
PLoS One. 2016 Sep 20;11(9):e0162607. doi: 10.1371/journal.pone.0162607. eCollection 2016.
7
Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease.
Macromol Biosci. 2015 Sep;15(9):1212-7. doi: 10.1002/mabi.201500062. Epub 2015 Jun 2.
9
Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.
J Drug Target. 2013 Dec;21(10):956-967. doi: 10.3109/1061186X.2013.837470. Epub 2013 Sep 16.

本文引用的文献

1
Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).
J Control Release. 2007 Oct 8;122(3):356-63. doi: 10.1016/j.jconrel.2007.05.032. Epub 2007 Jun 5.
2
Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review.
Br J Ophthalmol. 2007 Sep;91(9):1177-82. doi: 10.1136/bjo.2007.118562. Epub 2007 May 2.
3
Therapeutic targets in chronic myeloid leukaemia.
Hematol Oncol. 2007 Jun;25(2):66-75. doi: 10.1002/hon.813.
4
Antibodies and peptides in cancer therapy.
Crit Rev Ther Drug Carrier Syst. 2006;23(5):401-35. doi: 10.1615/critrevtherdrugcarriersyst.v23.i5.20.
5
Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma.
Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):163-72. doi: 10.1016/j.beem.2007.01.006.
6
Nanoconjugate based on polymalic acid for tumor targeting.
Chem Biol Interact. 2008 Jan 30;171(2):195-203. doi: 10.1016/j.cbi.2007.01.015. Epub 2007 Feb 8.
7
Glaucoma as a neurodegenerative disease.
Curr Opin Ophthalmol. 2007 Mar;18(2):110-4. doi: 10.1097/ICU.0b013e3280895aea.
8
The role of the thrombospondins in healing myocardial infarcts.
Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):21-7. doi: 10.2174/187152507779315813.
10
Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity.
Expert Opin Biol Ther. 2007 Feb;7(2):257-68. doi: 10.1517/14712598.7.2.257.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验